Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.

Raman SR, Man KKC, Bahmanyar S, Berard A, Bilder S, Boukhris T, Bushnell G, Crystal S, Furu K, KaoYang YH, Karlstad Ø, Kieler H, Kubota K, Lai EC, Martikainen JE, Maura G, Moore N, Montero D, Nakamura H, Neumann A, Pate V, Pottegård A, Pratt NL, Roughead EE, Macias Saint-Gerons D, Stürmer T, Su CC, Zoega H, Sturkenbroom MCJM, Chan EW, Coghill D, Ip P, Wong ICK.

Lancet Psychiatry. 2018 Oct;5(10):824-835. doi: 10.1016/S2215-0366(18)30293-1. Epub 2018 Sep 13.

PMID:
30220514
2.

Trends in ADHD medication use in children and adolescents in five western countries, 2005-2012.

Bachmann CJ, Wijlaars LP, Kalverdijk LJ, Burcu M, Glaeske G, Schuiling-Veninga CCM, Hoffmann F, Aagaard L, Zito JM.

Eur Neuropsychopharmacol. 2017 May;27(5):484-493. doi: 10.1016/j.euroneuro.2017.03.002. Epub 2017 Mar 20.

PMID:
28336088
3.

ADHD Medication Trends in Turkey: 2009-2013.

Öner Ö, Yilmaz EŞ, Karadağ H, Vural M, Vural EH, Akbulat A, Gürsöz H, Türkçapar H, Kerman S.

J Atten Disord. 2017 Dec;21(14):1192-1197. doi: 10.1177/1087054714523129. Epub 2014 Jan 1.

PMID:
24554298
4.

Patient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea.

Song I, Lee MS, Lee EK, Shin JY.

Asia Pac Psychiatry. 2018 Mar;10(1). doi: 10.1111/appy.12289. Epub 2017 Jun 20.

PMID:
28631372
6.

The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care.

McCarthy S, Wilton L, Murray ML, Hodgkins P, Asherson P, Wong IC.

BMC Pediatr. 2012 Jun 19;12:78. doi: 10.1186/1471-2431-12-78.

7.

Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.

Wong IC, Asherson P, Bilbow A, Clifford S, Coghill D, DeSoysa R, Hollis C, McCarthy S, Murray M, Planner C, Potts L, Sayal K, Taylor E.

Health Technol Assess. 2009 Oct;13(50):iii-iv, ix-xi, 1-120. doi: 10.3310/hta13490.

8.

Prevalence rates of youths diagnosed with and medicated for ADHD in a nationwide survey in Taiwan from 2000 to 2011.

Wang LJ, Lee SY, Yuan SS, Yang CJ, Yang KC, Huang TS, Chou WJ, Chou MC, Lee MJ, Lee TL, Shyu YC.

Epidemiol Psychiatr Sci. 2017 Dec;26(6):624-634. doi: 10.1017/S2045796016000500. Epub 2016 Jul 20.

PMID:
27435692
9.

Attention deficit hyperactivity disorder pharmacotherapy in Slovenian adults: a population-based study.

Stuhec M, Locatelli I.

Int J Clin Pharm. 2018 Apr;40(2):341-344. doi: 10.1007/s11096-018-0605-0. Epub 2018 Feb 21.

PMID:
29468526
10.

Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.

Winterstein AG, Gerhard T, Shuster J, Zito J, Johnson M, Liu H, Saidi A.

Ann Pharmacother. 2008 Jan;42(1):24-31. Epub 2007 Nov 27.

PMID:
18042808
11.

Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence.

Beau-Lejdstrom R, Douglas I, Evans SJ, Smeeth L.

BMJ Open. 2016 Jun 13;6(6):e010508. doi: 10.1136/bmjopen-2015-010508.

12.

Use of drugs for ADHD among adults-a multinational study among 15.8 million adults in the Nordic countries.

Karlstad Ø, Zoëga H, Furu K, Bahmanyar S, Martikainen JE, Kieler H, Pottegård A.

Eur J Clin Pharmacol. 2016 Dec;72(12):1507-1514. Epub 2016 Sep 1.

13.
14.
15.

Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.

Osland ST, Steeves TD, Pringsheim T.

Cochrane Database Syst Rev. 2018 Jun 26;6:CD007990. doi: 10.1002/14651858.CD007990.pub3. Review.

16.

Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry.

Cortese S, Panei P, Arcieri R, Germinario EA, Capuano A, Margari L, Chiarotti F, Curatolo P.

CNS Drugs. 2015;29(10):865-77. doi: 10.1007/s40263-015-0266-7.

PMID:
26293742
17.

Patterns of psychostimulant prescribing to children with ADHD in Western Australia: variations in age, gender, medication type and dose prescribed.

Preen DB, Calver J, Sanfilippo FM, Bulsara M, Holman CD.

Aust N Z J Public Health. 2007 Apr;31(2):120-6.

PMID:
17461001
18.

Trends in attention-deficit/hyperactivity disorder drug consumption in children and adolescents in Slovenia from 2001 to 2012: a drug use study from a national perspective.

Štuhec M, Locatelli I, Švab V.

J Child Adolesc Psychopharmacol. 2015 Apr;25(3):254-9. doi: 10.1089/cap.2014.0071. Epub 2015 Mar 24.

PMID:
25803789
19.

Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder.

Weisler RH, Pandina GJ, Daly EJ, Cooper K, Gassmann-Mayer C; 31001074-ATT2001 Study Investigators.

CNS Drugs. 2012 May 1;26(5):421-34. doi: 10.2165/11631990-000000000-00000.

PMID:
22519922
20.

Patterns and profiles of methylphenidate use both in children and adults.

Pauly V, Frauger E, Lepelley M, Mallaret M, Boucherie Q, Micallef J.

Br J Clin Pharmacol. 2018 Jun;84(6):1215-1227. doi: 10.1111/bcp.13544. Epub 2018 Apr 16.

Supplemental Content

Support Center